Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/59208
Título
L-citrulline supplementation and exercise in the management of sarcopenia
Autor
Año del Documento
2021
Editorial
MDPI
Descripción
Producción Científica
Documento Fuente
Nutrients 2021, vol.13, n. 9, 3133
Abstract
Sarcopenia is a process associated to aging. Persistent inflammation and oxidative stress in muscle favour muscle wasting and decreased ability to perform physical activity. Controlled exercise can optimize blood flux and moderate the production of reactive oxygen species. Therefore, supplements that can work as a vasodilators and control oxidative stress, might be beneficial for active elders. In this context, we have tested citrulline supplementation in a group of 44 participants aged from 60–73 years that followed a physical activity program adapted to their age and capacities. Volunteers were divided in two groups: placebo (n = 22) and citrullline supplemented (n = 22). Different physical tests and blood extractions were performed at the beginning and at the end of intervention (six weeks). Strength and endurance showed a tendency to increase in the citrulline supplemented group, with no significant differences respect to placebo. However, walking speed in the citrulline supplemented group improved significantly compared to placebo. Markers of muscle damage as well as circulating levels of testosterone, cortisol and vitamin D showed no significant changes, but a tendency to improve at the end of intervention in the supplemented group compared to placebo. Additional studies are necessary to confirm the effect of citrulline supplementation in sarcopenia delay.
Materias (normalizadas)
Fisiología
Geriatrics
Envejecimiento
Materias Unesco
2410.02 Anatomía Humana
2411.10 Fisiología del Músculo
Palabras Clave
Aging
Muscle wasting
Physical activity
Sarcopenia
Envejecimiento
Pérdida muscular
Actividad física
Revisión por pares
SI
Patrocinador
Caja Rural de Soria e Instituto de Investigación Sanitaria y Biomédica de Alicante (grant 190290)
Version del Editor
Propietario de los Derechos
© 2021 The Authors
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Collections
Files in this item
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional